Tag: cancer research

Oncotarget Editor-in-Chief Wafik S. El-Deiry Chairs 2025 WIN Symposium in Collaboration with APM in Philadelphia

October 1, 2025

The WIN Symposium featured as the Oncology Track at the APM Annual Conference 2025 unites global leaders in oncology, translational science, and precision medicine. BUFFALO, NY - October 1, 2025 – Oncotarget is proud… read more

Oncotarget

Loss of Trp53 Gene Promotes Tumor Growth and Immune Suppression in Ovarian Cancer

September 24, 2025

“These results highlight potential mechanisms by which loss of p53 function contributes to an immunosuppressive microenvironment in HGSC, and provide insight into the role of ovarian and peritoneal microenvironments in… read more

Oncotarget

Blocking Protein Control Pathway Slows Rhabdomyosarcoma Growth in Mice

August 29, 2025

“Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes.” BUFFALO, NY - August 29, 2025 – A… read more

Oncotarget

Behind the Study: R-spondin Family Roles in Metastatic Prostate Cancer

August 26, 2025

Aiden Deacon from the University of Minnesota-Twin Cities, Minneapolis, discusses a research paper he co-authored that was published in Volume 16 of Oncotarget, titled “Dissecting the functional differences and clinical… read more

Oncotarget

Aramchol Boosts Regorafenib Effectiveness in Gastrointestinal Tumors

August 19, 2025

“We determined in GI tumor cells that regorafenib interacted with aramchol to promote tumor cell killing.” BUFFALO, NY - August 19, 2025 – A new research paper was published in… read more

Oncotarget

FDA-Approved MI Cancer Seek Test Enhances Tumor Profiling for Precision Oncology

August 15, 2025

“Accordingly, MI Cancer Seek represents a safe and effective comprehensive molecular test option supporting biomarker-directed care for oncology patients.” BUFFALO, NY - August 15, 2025 – A new research paper… read more

Oncotarget

New Compound Disrupts Survival Pathways in Aromatase Inhibitor-Resistant Breast Cancer Cells

August 13, 2025

“The ability of PCAIs to mitigate various cancer hallmarks in the various cancer cell lines has been well established.” BUFFALO, NY - August 13, 2025 – A new research paper… read more